title: [Medical management of cervical arterial dissections].
abstract: Medical management of cervical arterial dissections is not standardized and has not been the subject of randomized trials. Management is mainly based on the presumed pathophysiology of secondary cerebral infarcts associated with dissections and the individual experience of each treating team. First, a review of the literature regarding medical management of acute and chronic dissections is presented. Then, results from a national study sponsored by the Société Française Neuro-Vasculaire and the Société Française de Neuro-Radiologie evaluating the medical management of this pathology in French neuro-vascular centers will be presented. These data will be useful to generate practical management recommendations and establish guidelines for further studies.
authors.affiliation: Fédération des Sciences Neurologiques, Centre Hospitalier Universitaire Jean Minjoz, 3 boulevard Fleming, 25030 Besançon. fabrice.vuillier@ufc-chu.univ-fcomte.fr
authors.forename: F
authors.initials: F
authors.lastname: Vuillier
authors.forename: L
authors.initials: L
authors.lastname: Tatu
authors.forename: T
authors.initials: T
authors.lastname: Moulin
mesh_terms: D000208:Acute Disease; D000784:Aortic Dissection / Q000150:complications / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000209:etiology; D002908:Chronic Disease; D004363:Drug Utilization; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005602:France; D006801:Humans; D009333:Neck / Q000098:blood supply*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000706:statistics & numerical data
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors